论文信息 - Six-year (yr) follow-up of patients (pts) with imatinib-resistant or -intolerant chronic-phase chronic myeloid leukemia (CML-CP) receiving dasatinib. - 字舞流文

Six-year (yr) follow-up of patients (pts) with imatinib-resistant or -intolerant chronic-phase chronic myeloid leukemia (CML-CP) receiving dasatinib.

H. Kantarjian | J. Cortes | G. Saglio | D. Healey | A. Hochhaus | C. Schiffer | F. Guilhot | N. Shah | Dong-Wook Kim | J. Steegmann | Hesham Mohamed | D. Dejardin